InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer’s New Studies Showcase INM-901’s Therapeutic Abilities
–News Direct– By Meg Flippin, Benzinga Whether due to an aging population or overall population growth, cases of Alzheimer's are increasing. As it stands, nearly seven million Americans suffer from …
InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer’s New Studies Showcase INM-901’s Therapeutic Abilities Read More